Our plain-English summary of Asbestos-associated diseases: lessons from the past for the future, by A. Fischbein, A.M. Langer, A.N. Rohl (JAMA, 1985).
You don't need the product names or old records. No fee unless we recover compensation for your family.
The study
- Authors: A. Fischbein, A.M. Langer, A.N. Rohl
- Journal: JAMA
- Published: 1985;254(10):1309-10
- Type of article: Case report, Letter
- Read it: PubMed
- In J-M's library: Johns-Manville's company medical library held a copy (J-M no. 001235).
In plain English
This item was a letter to the editor of JAMA, not a new study. The authors were replying to a commentary by Dr John Craighead that discussed, among other things, their earlier case report of pleural mesothelioma in a man who had worked in a factory next to a navy yard. The authors restated that amosite asbestos fibers were found in the man's lung tissue, both as free fibers and in the cores of asbestos bodies. They wrote that amosite was one of the major fiber types used on shipboard at that time. Detailed occupational and environmental histories found no other significant source of asbestos exposure besides his presence near the shipyard, and the authors followed him for over seven years. They rejected the suggestion that the case was overdiagnosed, stating that premortem and postmortem studies were conclusive of mesothelioma. The authors agreed with Dr Craighead that risk assessment for the general population exposed to low levels of fibers is very difficult and may be impossible. They concluded that new diagnostic and therapeutic techniques offer some hope of controlling the effects of past asbestos exposure.
We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.
What the study did and found
- Design: Letter to the editor (correspondence) defending the authors' own earlier case report; not a new study
- Who was studied: One man with pleural mesothelioma, the subject of the authors' earlier case report, who had worked in a factory next to a navy yard
- Exposure: Amosite asbestos, attributed by the authors to the man's presence in the immediate vicinity of a shipyard (navy yard) where amosite was a major fiber type used on shipboard
- Main results:
- Amosite asbestos fibers were observed in the man's lung tissue, both as free fibers and in the cores of asbestos bodies
- Detailed occupational and environmental histories found no other significant source of asbestos exposure except his presence in the immediate vicinity of the shipyard
- The authors followed the patient for over seven years
- The authors described the patient's unexpected longevity of ten years since the onset of symptoms as part of what made the case unusual
- The authors stated that premortem and postmortem studies were conclusive of the diagnosis of mesothelioma, and they regarded the diagnosis as firmly established
- The authors' conclusion: The authors considered that amosite in the lung tissue of a person with pleural mesothelioma, without other asbestos fibers or other relevant exposure history, strongly infers an etiological association. They agreed that risk assessment for the general population exposed to low levels of fibers is very difficult and may be impossible, but concluded that new diagnostic and therapeutic techniques provide some hope of controlling the effects of past asbestos exposure.
Topics
The National Library of Medicine indexes this study under subjects our site covers: Amosite, Mesothelioma.
Related studies
- Asbestos use and asbestos-related diseases in Asia: past, present and future — G.V. le, K. Takahashi, et al. (2011)
- Assessment of the future mesothelioma disease burden from past exposure to asbestos in ship recycling yards in India — R. Singh, J.W. Cherrie, et al. (2020)
- Cancer Prevention: Lessons Learned and Future Directions — B.K. Dunn, B.S. Kramer (2016)
- Estimation of the past and future burden of mortality from mesothelioma in France — A.G. Ilg, J. Bignon, et al. (1998)
- Exposure to asbestos: past, present and future — E. Pira, F. Donato, et al. (2018)
- Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and Future — G. Reid, T.G. Johnson, et al. (2020)
Browse more research in JAMA, or return to medical research.
How to cite it
Cite the study
A. Fischbein, A.M. Langer, A.N. Rohl. Asbestos-associated diseases: lessons from the past for the future. JAMA 1985;254(10):1309-10. PMID: 2862294.
Cite our summary
“Asbestos-associated diseases: lessons from the past for the future.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/asbestos-associated-diseases-lessons-from-the-past-for-the-future.
ACL Doc numbers and their short links never change. See how to cite the Library.
Talk with an asbestos lawyer
Start with what you remember, and we'll take it from there.
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.